Loading...
XSAU
4004
Market cap4.05bUSD
Nov 12, Last price  
150.00SAR
Name

Dallah Healthcare Company SJSC

Chart & Performance

D1W1MN
XSAU:4004 chart
P/E
32.22
P/S
4.74
EPS
4.65
Div Yield, %
1.00%
Shrs. gr., 5y
2.28%
Rev. gr., 5y
20.69%
Revenues
3.21b
+8.93%
527,343,715637,058,049749,653,235895,103,764985,441,1971,162,788,9871,212,076,3151,180,942,0511,252,088,6771,318,253,9952,105,179,1072,487,983,1352,942,897,7013,205,734,000
Net income
471m
+30.84%
113,401,424133,359,957136,632,897147,114,745165,057,068225,832,401294,976,212141,758,455146,915,95297,127,177258,601,120274,463,823360,122,537471,202,000
CFO
678m
+8.39%
128,040,565125,010,944106,903,532149,436,728214,313,937341,570,910353,070,125204,680,012307,126,808183,301,268361,549,012442,131,337625,783,845678,287,000
Dividend
Aug 25, 20240.5 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dallah Healthcare Company provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical policlinics, compounds, and lands; and the provision of manpower and support services to hospitals and medical centers. It also manufactures and distributes pharmaceutical, herbal, and cosmetic products to retail pharmacies, health and beauty stores, hospitals, and governmental agencies. In addition, the company engages in the management and operation of hospitals owned by third parties; and the provision of other support services. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was founded in 1994 and is based in Riyadh, Saudi Arabia. Dallah Healthcare Company is the subsidiary of Dallah Al-Barakah Holding.
IPO date
Dec 16, 2012
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT